Teriflunomide Accord Europska Unija - islandski - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi, sérhæfður ónæmisbælandi - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Coversyl Novum Filmuhúðuð tafla 5 mg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

coversyl novum filmuhúðuð tafla 5 mg

les laboratoires servier* - perindoprilum arginín - filmuhúðuð tafla - 5 mg

Klyx Endaþarmslausn Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

klyx endaþarmslausn

ferring lægemidler a/s (f) - docusatum natricum inn; sorbitolum - endaþarmslausn

Optovite B12 Stungulyf, lausn 1000 míkróg Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

optovite b12 stungulyf, lausn 1000 míkróg

laboratorios normon s.a. - cyanocobalaminum inn - stungulyf, lausn - 1000 míkróg

Rompun vet. Stungulyf, lausn 20 mg/ml Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

rompun vet. stungulyf, lausn 20 mg/ml

elanco animal health gmbh - xylazinum hýdróklóríð - stungulyf, lausn - 20 mg/ml

Dermovat Krem 0,5 mg/g Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

dermovat krem 0,5 mg/g

glaxosmithkline pharma a/s - clobetasolum própíónat - krem - 0,5 mg/g

Kenacort-T Stungulyf, dreifa 40 mg/ml Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

kenacort-t stungulyf, dreifa 40 mg/ml

bristol-myers squibb ab* - triamcinolonum acetóníð - stungulyf, dreifa - 40 mg/ml